NCT01641120View on ClinicalTrials.gov

Assessing Tolerability of Avonex Intramuscular Injections

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Multiple Sclerosis
Interventions
DRUG

Avonex

Intramuscular injection administered using 25 gauge or 30 gauge needle

Trial Locations (1)

06112

The Mandell Center for Multiple Sclerosis, Hartford

Sponsors

Collaborators (1)

Biogen
All Listed Sponsors
collaborator

Biogen

INDUSTRY

lead

Trinity Health Of New England

OTHER